Andaman7 Achieves Global eHealth Interoperability

Belgian-American e-health company Andaman7 is celebrating a ‘world first’ after patients collected their health data via their smart phone from both US and EU-based hospitals. The moment marked a major milestone in global health interoperability and patient empowerment.
Andaman7 was established by Vincent Keunen, himself a cancer survivor and now active patient advocate, to improve communication across the health ecosystem, between patients, doctors, and researchers. The company provides innovative software technology, with security by design and privacy by default, enabling patients to get full control of their health data. A medical app gives each patient a global view and access to all their health data which they can continually collect, share and control as a Personal Health Record (PHR).
‘More engaged patients with better health outcomes can help save time and money and aid in the development of more efficient therapies. We believe this is a world premiere. Medical records’ access and interoperability is a significant problem – even hospitals in the same country struggle to correctly exchange data. Achieving international interoperability moves the goalposts significantly.’
The step forward was achieved by Andaman7 normalising health data in the PHR, meaning several exchange protocols, formats and interfaces are used to grab the data and store it in a uniform manner inside patient’s smartphones. Storage of the data in a smartphone is key – not only does the patient have instant access to their data but it is more secure than cloud-based systems and under the patient’s total control.
Andaman7’s software also delivers wider health value through Electronic Patient Reported Outcomes (ePRO), Real World Evidence (RWE) and remote patient monitoring.
‘Navigating the medical system can be a stressful experience, over and above the stress related to your own medical condition. Being in charge of our own health data and able to ensure a smooth transition of our medical records from the USA to Belgium feels right. In addition, we can share our health records with each other, and with other health professionals as needed. It can only be hoped this becomes a common option, just like the value we place on storing our personal photos on a phone. What could be more valuable than your own portable, accurate health record.’
This innovation has far-reaching implications for the collection of Real-World Data (RWD) and the forming of Real-World Evidence (RWE). The next step, with patient consent, is to send data back to the hospitals – something Andaman7 is ready for.
The developments are also testament to the work of a European group known as InteropEHRate, who recently published a Whitepaper in August 2021, funded by the European Union’s Horizon 2020 research and innovation programme, entitled
‘.
InteropEHRate aims to unleash health data from local silos and offer more power to citizens in managing their own health data across different health providers and countries. Citizens’ access to personal health data supports patient empowerment and self-care and can contribute significantly to medical research. This benefits continuity of care between healthcare providers at national level and across borders.
Andaman7 is a Belgian-American eHealth company and was created to significantly improve communication and efficiency in collaboration between healthcare actors: patients, doctors, and researchers. The company’s particular strengths are in RWE, QoL, PRO studies.?Andaman7 ‘s patient centric health intermediation platform is designed to:?
1 – help patients better manage their health data??
2 -enable outcome measurement for pharma and research??
3 – support disease management for hospitals and doctors.????
Andaman7’s unique “security by design and privacy by default” architecture does not store medical data in the cloud. Data is only stored on the edge of the network (on mobile devices) and exchanged in a distributed peer to peer method.?Andaman7 is compliant with GDPR and HIPAA?and is also validated FDA 21 CFR part 11 and EU Annex 11 for clinical trials.??Andaman7 is in use by citizens of over 30 countries and available in 20 languages.?

Source link: World Pharma Today
Latest News Explore all